Document DMgkq5mK10kg6bQ84MXdEwwdn

From: Sent: To: Cc: Subject: Tsai, Shan SP SHLOIL-SPS Wednesday, August 2,20008:56 PM (GMT) Cagen, Stuart SZ SCC <SC724012@MSXSCC.SHELL.COM>; Clegg, Patsy PM SCC <PH197432@MSXSCC.SHELL.COM> Kirsch, Glenda GH SHLOIL <GK200933@MSXSOC.SHELL.COM> RE: Benzene Epi Mtg 2 I have a videoconference on 8/31. I trust that Stu will brief us after the meeting. Shan -----Original Message----From: Cagen, Stuart SZ SCC Sent: Wednesday, August 02,20004:00 PM To: Clegg, Patsy PM SCC; Tsai, Shan SP SHLOIL-SPS Cc: Kirsch, Glenda GH SHLOIL Subject: RE: Benzene Epi Mtg 2 I am available and interested -----Original Message----From: Clegg, Patsy PM SCC Sent: Wednesday, August 02,20003:58 PM To: Cagen, Stuart SZ SCC; Tsai, Shan SP SHLOIL-SPS Cc: Sullivan, Nancy NE SCC-CBAR; Kirsch, Glenda GH SHLOIL Subject: FW: Benzene Epi Mtg 2 Stu and Shan, Below is the announcement about the next Benzene Epi meeting to be help August 31. Unfortunately, I will be in London that week. Would one or both of you please attend for Shell? If so, please respond to Paula directly. If you cannot attend, please let me know so we can make arrangements for someone else from Shell to attend. Appreciate your sharing any handouts and having a debriefing session when you return. Patsy -----Original Message----From: Paula Podhasky [SMTP:podhaskyp@api.org] Sent: Wednesday, August 02,2000 12:18 PM To: 'Beatty, Patrick'; 'arschna@erenj.com'; 'bill.d.broddle@usa.conoco.com'; 'burnetdm@bp.com'; 'carol.a.fairbrother@exxon.com'; 'cclark1@tosco.com'; 'cmparker@mapllc.com'; 'fjudy.elledge@usa.conoco.com'; 'hwinger@cl-Iaw.com'; 'jdps@chevron.com'; 'Iynn.b.russo@exxon.com'; 'masethwe@bp.com'; 'myron.c.harrison@exxon.com'; 'ottowong@aol.com'; 'pmclegg@shellus.com'; 'podhaskyp@api.com'; 'pwbe@chevron.com'; 'richard.irons@uchsc.com'; 'roythorc@pb.com'; 'rudy_breglia@sunoil.com'; 'suzanne.covello@cmahg.com'; 'twarmst@erenj.com'; Nancy Newkirk; Lorraine Twerdok; George Woodall Subject: Benzene Epi Mtg 2 Dear Benzene Research Interested Stakeholder, This note is to inform you that a second meeting of potential members of the consortium for epidemiological research on benzene in Shanghai has been scheduled for August 31, 2000 starting at 9:00 AM at the American Petroleum Institute headquarters in Washington, D.C. At this time we have received expressions of interest in proceeding to this next step from most of the companies present at our June 12 meeting at which the proposed research program was presented. The purpose of the August 31 meeting is to address a number of issues that have been identified as crucial to membership by a number of companies. These are the basis for cost sharing and the manner in which the ethical SHELL-MCCLURG-051576 considerations of working with human volunteers would be addressed. In addition, plans to solicit membership from European benzene producers and a proposal for the infrastructure of the consortium will be presented for discussion and approval. The Benzene Task Force has retained an internationally known bioethicist, Dr. Baruch Brody of Baylor University College of Medicine (Houston, TX), to assist us in drafting a plan to identify and address the bioethics issues involved in our proposed research plan. The August 31 meeting date was chosen to allow Dr. Brody to be present at the meeting. Please consult with the appropriate individuals to determine what options for financial sharing (E.G. Equal Shares; Membership Levels Based on Company Size) are acceptable to your company and come prepared to discuss these. We intend that the next step forward on the path to consortium formation after this meeting will be for each company to determine a level of financial support to which it is willing to commit and to agree to terms of membership that will be drawn up based upon the agreements made at this meeting. It is imperative that we move forward with forming the consortium in order to demonstrate to our Chinese collaborators that we are committed to the research and to provide funding for protocol development and placing of the laboratory facilities in Shanghai. This meeting is critical to formation of the consortium and all interested companies need to be represented. If you cannot attend, please arrange for an alternate from your company. Due to the number of issues to be addressed the meeting will start at 9:00 AM and attendees should be prepared to stay until 3:00 PM. A follow-up mailing will be coming shortly with pre meeting attachments including a draft agenda, Dr. Brody's bio, a summary of the plan to address the bioethics considerations, and ADDITIONAL sample cost sharing arrangements from other industry consortia. Please RSVP to Paula Podhasky at API (podhaskyp@api.org <mailto:podhaskyp@api.org> , (202) 682-8333). Sincerely, SHELL-MCCLURG-051577